
Mirakare Pharmaceuticals Private Limited
About Mirakare Pharmaceuticals Private Limited
Data last updated:
Mirakare Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 19 October 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC421682.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arun Ahuja and Ramesh Rupaal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. B – 6 – B Basement, Prabhat Kiran Building 17, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2024, the company reported a revenue of ₹84,739. For the same year it recorded a net loss of ₹2,870 (net margin -3.4%) and EBITDA of -₹2,858 (EBITDA margin -3.4%).
Company details
Contact details
Mirakare Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressFlat No. B – 6 – B Basement, Prabhat Kiran Building 17, New Delhi, Delhi, India – 110008
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mirakare Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mirakare Pharmaceuticals Private Limited, buy the company report.
Financials of Mirakare Pharmaceuticals Private Limited
FY 2025 filings availableMirakare Pharmaceuticals Private Limited reported revenue of ₹84,739 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹2,858 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹2,870 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | -3.4% |
| Net Profit Margin | -3.4% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Mirakare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mirakare Pharmaceuticals Private Limited
Mirakare Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Ahuja | Director | 19 Oct 2023 | 3 Years 0 Months | Current |
| Ramesh Rupaal | Director | 19 Oct 2023 | 3 Years 0 Months | Current |
Peer comparison
Mirakare Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mercure Pharmaceuticals (OPC) Private Limited | ₹85,541 (FY 2025) | 4.0% | Indore, Madhya Pradesh, India | |||
| Savio Remidies Pharmaceuticals Private Limited | ₹85,506 (FY 2024) | -76.0% | Jabalpur, Madhya Pradesh, India | |||
| Bioxima Pharmaceuticals Private Limited | ₹85,392 (FY 2021) | -32.0% | New Delhi, Delhi, India | |||
| Sheer Health Pharmaceuticals Private Limited | ₹84,989 (FY 2023) | -62.0% | Roorkee, Uttarakhand, India | |||
| Mirakare Pharmaceuticals Private Limitedthis company | ₹84,739 (FY 2024) | -₹2,870 | -3.4% | New Delhi, Delhi, India | ||
| Nyctanthes Pharmaceuticals Private Limited | ₹83,133 (FY 2025) | -86.0% | Dehradun, Uttarakhand, India | |||
| Elipis Pharmaceuticals Private Limited | ₹83,000 (FY 2024) | -60.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Mirakare Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mirakare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mirakare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mirakare Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mirakare Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Arun Ahuja was appointed as Director on 19 Oct 2023.
Frequently asked questions
Mirakare Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 19 October 2023 (3+ years old) and is registered under CIN U46497DL2023PTC421682.
Mirakare Pharmaceuticals has 2 current directors:
- Arun Ahuja - Director
- Ramesh Rupaal - Director
The latest financial statements of Mirakare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Mirakare Pharmaceuticals is U46497DL2023PTC421682. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mirakare Pharmaceuticals was incorporated on 19 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mirakare Pharmaceuticals by revenue are Mercure Pharmaceuticals (OPC) Private Limited, Savio Remidies Pharmaceuticals Private Limited, Bioxima Pharmaceuticals Private Limited, Sheer Health Pharmaceuticals Private Limited, Nyctanthes Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arun Ahuja was appointed as Director on 19 Oct 2023. Ramesh Rupaal was appointed as Director on 19 Oct 2023.
The registered office of Mirakare Pharmaceuticals is at Flat No. B – 6 – B Basement, Prabhat Kiran Building 17, New Delhi, Delhi, India – 110008.
Mirakare Pharmaceuticals can be reached at its registered office: Flat No. B – 6 – B Basement, Prabhat Kiran Building 17, New Delhi, Delhi, India – 110008.
Mirakare Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

